81.40
1.10 (1.37%)
| Penutupan Terdahulu | 80.30 |
| Buka | 80.50 |
| Jumlah Dagangan | 1,774,837 |
| Purata Dagangan (3B) | 2,797,251 |
| Modal Pasaran | 353,001,952 |
| Harga / Jualan (P/S) | 2.57 |
| Harga / Buku (P/B) | 2.35 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Jun 2025 |
| Margin Operasi (TTM) | -28,151.33% |
| EPS Cair (TTM) | -0.090 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -5.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 260.92% |
| Nisbah Semasa (MRQ) | 1.08 |
| Aliran Tunai Operasi (OCF TTM) | -23.60 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -31.40 M |
| Pulangan Atas Aset (ROA TTM) | -32.74% |
| Pulangan Atas Ekuiti (ROE TTM) | -224.77% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (GB) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | AVACTA GROUP PLC ORD 10P | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -5.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 2.0 |
| Purata | -0.75 |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| AVACTA GROUP PLC ORD 10P | 353 M | - | - | 2.35 |
| PHARMA MAR SA PHARMA MAR ORD SH | 16 B | 1.08% | 14.69 | - |
| ARROWHEAD PHARMACEUTICALS INC A | 4 B | - | - | - |
| GENUS PLC ORD 10P | 2 B | 0.01% | 81.55 | 3.61 |
| BASILEA PHARMACEUTICA AG BASILE | 511 M | - | - | 6.18 |
| PROTHENA CORPORATION PLC PROTHE | 330 M | - | 7.53 | - |
|
Avacta Group PLC is a United Kingdom-based biotechnology company. The company offers its products through three segments that are Diagnostics, Therapeutics, and Animal Health. The company is developing novel cancer immunotherapies combining its two proprietary platforms Affimer biotherapeutics and precision tumor-targeted chemotherapy. The company operates in the United Kingdom, France, South Korea, Rest of Europe, Asia, and North America. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 37.16% |
| % Dimiliki oleh Institusi | 6.17% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |